
Journal of Medicinal Chemistry p. 1364 - 1368 (1993)
Update date:2022-09-26
Topics:
Florent, Jean-Claude
Gaudel, Gilbert
Monneret, Claude
Hoffmann, Dieter
Kraemer, Hans-Peter
The synthesis and biological activity of the new 4-demethoxyanthracyclines 15, 22, and 23 are reported.They were obtained from synthetic 9-deacetyl-9-(hydroxymethyl)-4-demethoxydaunomycinone (isopropylidene derivative 9) and from 4-azido- or 4-amino-2,4,6-trideoxy-L-lyxo-hexoses.Anthracycline 22 (hydrochloride salt), the most active compound in the series, was slightly more potent than doxorubicin in vitro against three cell lines (L1210, HT29, A549).It was found to exhibit similar antitumor activity in vivo (iv route) against L1210 leukemia, but was less activethan doxorubicin against three human tumors in a subrenal capsule assay (LX, A549, and HT29).
View MoreNanjing distinctions Medical Technology Co., Ltd.(expird)
Contact:+86-15996203785 13914714059
Address:nanjing,jiangsu , China
Nanjing distinctions Medical Technology Co., Ltd.(expird)
Contact:+86-15996203785 13914714059
Address:nanjing,jiangsu , China
Hubei Lansun Biochemical Pharmaceutical Co., Ltd
Contact:714-6395977
Address:No. 81 Pengcheng Avenue, economic and technological development zone, Huangshi City, Hubei Province,China
Sichuan Sangao Biochemical Co., Ltd
Contact:+86-28-84874233
Address:19F, Bldg.2, Shudu Center, Tianfu 2nd St., Hi-tech zone, Chengdu 610041, Sichuan Province, China.
Xi'an Tizan Tech & Industry Co., Ltd.
Contact:86-18629066522
Address:C3009 TANG FENG INTERNATIONAL PLAZA, NO.18 FENGHUI NAN ROAD, XI'AN HIGH TECH ZONE, 710075 CHINA.
Doi:10.1016/j.jfluchem.2011.06.031
(2011)Doi:10.1055/s-1996-4196
(1996)Doi:10.1016/j.tetlet.2011.08.130
(2011)Doi:10.1021/jo00014a032
(1991)Doi:10.1039/c4ra07983c
(2014)Doi:10.1021/ic200872a
(2011)